Speaker :

Professor Sherief Khalifa

Vice Chancellor for Quality & Global Engagement
Dean, College of Pharmacy – Gulf Medical University

Bio:

Dr. Sherief Khalifa received his BSc (Pharm) at King Saud University in 1986, and his PhD at the University of Mississippi (USA) in 1994. After graduation, he joined Suez Canal University and then Misr International University (MIU) in Egypt. Before leaving MIU to join Qatar University, Dr. Khalifa was Professor and Head, Department of Pharmacy Practice and Clinical Pharmacy. Professor Khalifa held adjunct appointments with the University of Mississippi, USA and Ain Shams University, Egypt. He also received a Fulbright Research & Teaching Scholarship at Georgia State University in 2001. Throughout his academic career, Dr. Khalifa was instrumental in establishing linkages between Universities in the Middle East and USA-based academic institutions. Dr. Khalifa joined the College of Pharmacy at Gulf Medical University in August of 2017 as Professor and Dean. During his first year in office he led the accreditation efforts for the PharmD and the Master in Clinical Pharmacy programs. Both programs received accreditation by the Commission for Academic Accreditation, Ministry of Education, UAE. During his second year, he led the certification of GMU PharmD program by the American Accreditation Council for Pharmacy Education (ACPE). In addition to his Deanship, he currently serves as Vice Chancellor for Quality and Global engagement at Gulf Medical University. He also serves as a member of the International Commission of ACPE.

Speaker :

Dr. Ahmed Thabet Negmeldin

Chair and Assistant Professor, Department of Pharmaceutical Sciences,
Program Director, Master of Science in Drug Discovery and Development (MDD),
College of Pharmacy – Gulf Medical University

Bio:

Dr. Ahmed Thabet graduated from Faculty of Pharmacy, Cairo University, Cairo, Egypt with a bachelor degree in pharmacy and pharmaceutical sciences with honors in 2006. He was hired as a demonstrator at the same university where he received his master’s degree in pharmaceutical organic chemistry in 2011. Dr. Ahmed received his Ph.D. from Wayne State University, Detroit, MI, USA, in 2017 where he worked with Mary Kay Pflum on the design, synthesis, molecular docking and biological screening of several small molecules targeting different HDAC isoforms as anti-cancer agents. Later he joined College of Pharmacy, Gulf Medical University as an assistant professor of medicinal chemistry in 2018 and is currently serving as chair of the department of pharmaceutical sciences since April 2019. Dr. Ahmed has more than 13 years of research experience in drug design, medicinal chemistry, organic chemistry, chemical synthesis, molecular docking, and biological screening of inhibitors. He also has 13 years of teaching experience at different universities in the US, Egypt, and UAE. He is a recipient of 7 awards Wayne State University for outstanding research and/or academic records and 3 awards at for excellence in teaching. His research interest is rational design and computer-aided drug design of anti-cancer agents.

Speaker :

Dr. Ahmed Al abd

Associate Professor of Pharmacology and Toxicology,
Department of Pharmaceutical Sciences
College of Pharmacy & Thumbay Research Institute for Precision Medicine (TRIPM)
Gulf Medical University

Bio:

Dr. Ahmed M Al-Abd has graduated (2000) in the faculty of pharmacy, Ain Shams University; M.Sc. in pharmacology and toxicology (2004-Ain Shams University); Ph.D. fellow in biomedical sciences (the year 2008- the Catholic University of Korea); Ph.D. degree in pharmacology and toxicology (year 2011- Beni-Suif University, Egypt). Since graduation, He has been promoting in the fields of research/academia from research assistant, to associate research professor at the National Research Centre of Egypt. He worked for 6 years as an Assistant/Associate Professor at King Abdulaziz University; during these 6 years he supervised the research activities within Tissue Culture facility in the Faculty of Pharmacy, King Abdulaziz University. In addition, he worked as a visiting scholar in Bouvé College of Health Sciences, Northeastern University, Boston, MA, USA (years 2014 – 2018). He is currently working as an Associate Professor of Pharmaceutical Sciences at the College of Pharmacy and Thumbay Research Institute of Preision Medicine, Gulf Medical University, United Arab Emirates. Dr. Ahmed Al-Abd is a reaserch active University Faculty Staff member who accomplished more than 15 research grants with total budget exceeding USD 2 millions. By Sept-2020, Dr. Al-Abd is an author in more than 50 peer-reviewed publications and 3 books/book chapters. Dr. Al-Abd has a Scopus H-index of 19; google scholar H-index of 22 and google scholar i10-index of 37. In addition to be an editor in 6 peer reviewed International Scientific Journals, Dr. Al-Abd has a broad international scientific communication network (collaborator with more than 150 authors in more than 20 Universities and Research institutes in more than 8 different countries worldwide, and supervised the M.Sc. and Ph.D. theses of 16 candidates affiliated to 5 Universities and Research institutes).

Speaker :

Dr. Eman M. El-labbad

Assistant Professor Pharmaceutical Chemistry
Department of Pharmaceutical Sciences,
College of Pharmacy -Gulf Medical University

Bio:

• Eman Moussa El-labbad, Assistant Professor of Pharmaceutical Chemistry at Pharmaceutical Sciences Department, College of Pharmacy, Gulf Medical University, Ajman, UAE since January 2020.
• Eman had started her research and academic career in 2006 as teaching staff and postgraduate student in Pharmaceutical Chemistry Department, College of Pharmacy, Ain Shams University, Cairo, Egypt Where she progressed in her career with major interest in organic chemistry, computational chemistry, medicinal chemistry and drug design.
• During 2014-2017, Dr. Eman was awarded Joint supervision PhD grant from the Egyptian Ministry of Higher Education where she was hosted by Prof. Dr. Binghe Wang in chemistry department, College of Arts and Science, Georgia State University, Atlanta, USA. Dr. Eman worked in Dr. Wang’s lab on gasotransmitters projects specifically on applying click chemistry to design and synthesize SO₂ prodrugs with tunable release rate.
• Eman research involve the design and synthesis of new organic compounds having potential pharmaceutical application with focus on antiviral, anticancer and gasotransmitters. In addition to the application of computational chemistry in silico prediction of the mechanism of action of newly identified natural products and immunoinformatic analysis fungal/bacteria secretome.

Speaker :

Professor Allan H. Young
MB, ChB, MPhil, PhD, FRCP (Edin.), FRCPC, FRCPsych . Director of the Centre for Affective Disorders in the Department of Psychological Medicine at King’s College London.

Profile:

Chair of Mood Disorders and is Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London (where he is also interim Vice-Dean for Academic Psychiatry), United Kingdom (UK).

Clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.

Speaker :

Morten Andreas Hjulsager
Past Deputy Director General for Danish Consumer Agency, Head of Division of Danish National Board of Health and Danish HTA Agency, Danish Government Representative at EU, OECD and WHO and currently Oncology Market Access Director for MSD.

Profile:
Leadership in private and public health organisations, since 1999. Top-level Market Access expert, pharmaceutical access and pricing since 2011. Extensive experience with pricing, reimbursement and funding for medicines and vaccines, HTA and health economics, health RWE and epidemiology, healthcare outcome measures.

Professional qualifications
Master’s degree in economics (1995). Various leadership positions in private and governmental health organisations since 1999, focusing on improving patient access and quality of healthcare via health policy and pharmaceutical market access. Ass. Professor at University of Copenhagen, Department of Economics. Author of economic textbooks.

Speaker :

Paul W. Bush, PharmD, MBA, BCPS, FASHP
Vice President, Global Resource Development and Consulting
ASHP
Clinical Professor (Adjunct)
University of North Carolina Eshelman School of Pharmacy
Professor of Pharmacy Practice
Campbell University College of Pharmacy and Health Sciences

Speaker :

Filipa Alves da Costa, PhD

Bio:

• Invited Professor, Department of Social Pharmacy, Faculty of Pharmacy, University of Lisbon, Institute Egas Moniz Portugal
• Public Health Consultant
• Dr Filipa Alves da Costa has been focusing her research on pharmacoepidemiology and outcomes research, namely on the responsible use of medicines.
• has a special interest on the development of innovative pharmacy services, on adherence and polypharmacy.

Speaker :

Prof. Konstantinos P.Tsioufis. MD, PhD, FESC, FACC 

Bio:

• Professor of Cardiology and Director of the Hypertension Unit of the Hippokration Hospital National and Kapodistrian University of Athens, Greece
• He was a post-doctoral fellow at the Veterans Affairs Medical Centre, Georgetown University Washington DC USA.
• He has more than 400 publications inpeer-reviewed Journals, more than 11000 citations and more than 450 invited lectures at international meetings.
• Co-editor of the books ‘’interventional therapies of secondary and essential hypertension’’ and ‘’ ESH Manual of Hypertension, 5th edition, 2019’’ .
• He has contributed with more than 20 Chapters in Books. Member of the Editorial Board and Reviewer in many Cardiology and Hypertension Journals .
• Prof Tsioufis has served as President of European Society of Hypertension (ESH) (2017-19) and President of the Hellenic Society of Cardiology (2016-18)

Speaker :

Björn Vandewalle

Bio:
Björn Vandewalle has a PhD Mathematics from the Catholic University of Leuven, Belgium. He has experience in leading teams of health economic modellers and statisticians in a variety of projects, both national and international, using techniques going from simple Markov modelling, over discrete event, agent-based and system dynamics modelling, survival analysis, extreme value statistics, data envelopment analysis, indirect treatment comparisons and network meta-analysis. He is currently vice-director at Exigo responsible for science and innovation.